Archive · Ars Technica
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Ars Technica →